A study by Carr et al. (9) examined the effects of the CCT family genes on the development of hepatocellular carcinoma by examining the protein levels of CCT subunits in hepatocellular carcinoma, prostate cancer, and lung cancer, where higher levels of CCT2 were detected than in normal tissue. This evidence concerns the gene FLVCR2 and prostate cancer.